Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

Back

ESC Professional Premium Access

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Topic: Device Treatment

Speaker: Miss S. Pepplinkhuizen (Amsterdam, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Miss Shari Pepplinkhuizen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

1 presentation

0 follower

6 more presentations in this session

Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial

Speaker: Miss S. Pepplinkhuizen (Amsterdam, NL)

Defibrillation success with a second generation intercostal extravascular ICD lead and commercially available left pectoral pulse generator

Speaker: Doctor M. Burke (Chicago, US)

A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis

Speaker: Doctor H. Eldeeb (Leicester, GB)

Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients

Speaker: Ms J. De Veld (Amsterdam, NL)

long term follow up of Implantable Cardioverter Defibrillators (ICD) in hypertrophic cardiomyopathy: is subcutaneous the way forward?

Speaker: Mr C. Monkhouse (London, GB)

Access the full session

Subcutaneous and extravascular defibrillators: already mainstream?

Speakers: Miss S. Pepplinkhuizen, Miss S. Pepplinkhuizen, Doctor M. Burke, Doctor H. Eldeeb, Ms J. De Veld...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources